XML 44 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements - Narrative (Details)
$ in Thousands
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent royalty obligation payable to Evolus Founders $ 44,551 $ 44,765 $ 44,779 $ 45,030
Estimate of Fair Value Measurement | Pharmakon Term Loans        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent royalty obligation payable to Evolus Founders $ 131,964 $ 132,078    
Contingent Royalty Obligation | Measurement Input, Discount Rate | Maximum        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Measurement input 0.13 0.14